Skip to main content

Table 1 Baseline of clinicopathologic characteristics (N = 2088)

From: Development and validation of a clinical prediction model for endocervical curettage decision-making in cervical lesions

Characteristics

ECC positive (N = 450)

ECC negative (N = 1638)

χ2

P-value

Agea

52 (45, 60)

46 (38, 54)

  

Age groups

  

132.498

< 0.001

 ~ 30

3 (0.7%)

104 (6.3%)

  

 30 ~ 39

54 (12%)

389 (23.7%)

  

 40 ~ 49

117 (26%)

549 (34%)

  

 50 ~ 59

152 (33.7%)

425 (26%)

  

 60~

124 (27.6%)

171 (10%)

  

Menopause

  

97.411

< 0.001

 No

172 (38%)

1050 (64%)

  

 Yes

278 (62%)

588 (36%)

  

Symptom of contact bleeding

  

180.108

< 0.001

 No

282 (63%)

1461 (89%)

  

 Yes

168 (37%)

177 (11%)

  

HPV status

  

426.073

< 0.001

 HPV negative

32 (7.1%)

197 (12%)

  

 HPV16+

264 (59%)

462 (28.2%)

  

 HPV18+

23 (5.1%)

145 (8.9%)

  

 HPV16 and 18+

7 (1.5%)

14 (0.9%)

  

 HR-HPV+ (non 16/18 types)

120 (27%)

790 (48.2%)

  

 LR-HPV+

4 (0.8%)

30 (1.8%)

  

TCT

  

983.804

< 0.001

 NILM

119 (26%)

1000 (61%)

  

 ASC-US

120 (27%)

379 (23%)

  

 LSIL

52 (12%)

175 (11%)

  

 ASC-H

40 (8.9%)

34 (2.1%)

  

 HSIL

96 (21%)

45 (2.7%)

  

 SCC

20 (4.4%)

2 (0.1%)

  

 AGC-NOS

1 (0.2%)

3 (0.2%)

  

 AGC-FN

1 (0.2%)

0 (0%)

  

 AIS

0 (0%)

0 (0%)

  

 AC

1 (0.2%)

0 (0%)

  

Cervix visibility

  

28.407

< 0.001

 Inadequate

9 (2.0%)

0 (0%)

  

 Adequate

441 (98%)

1638 (100%)

  

Original squamous epithelium ectopia

  

23.972

< 0.001

 No

414 (92%)

1353 (83%)

  

 Yes

36 (8.0%)

285 (17%)

  

Cervical artrophy

  

18.697

< 0.001

 No

350 (78%)

1411 (86%)

  

 Yes

100 (22%)

227 (14%)

  

TZ type

  

112.127

< 0.001

 Unrecognizable

16 (3.6%)

2 (0.1%)

  

 Type I

11 (2.4%)

122 (7.4%)

  

 Type II

309 (69%)

1320 (81%)

  

 Type III

114 (25%)

194 (12%)

  

Acetowhite changes

  

407.653

< 0.001

 None

49 (11%)

514 (31%)

  

 Thin

112 (25%)

851 (52%)

  

 Dense

289 (64%)

273 (17%)

  

Lugol staining

  

20.578

< 0.001

 Nonstained

443 (98%)

1518 (92.7%)

  

 Stained

7 (1.6%)

120 (7.3%)

  

Colposcopic impression

  

676.089

< 0.001

 Normal/benign

50 (11%)

628 (38.3%)

  

 Low-grade

99 (22%)

739 (45.1%)

  

 High-grade

137 (30.4%)

253 (15.4%)

  

 Cancer

164 (36.4%)

18 (1.1%)

  
  1. aStatitics presented: Median (IQR); n (%)